Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, November 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 8 X users

patent: 5 patents
facebook: 2 Facebook pages
googleplus: 1 Google+ user

Readers on

mendeley: 94 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Antibodies targeting glioblastoma stem-like cells and methods of use thereof

Grant US-12742019-B2

United States of America

22 Sep 2026

Antibodies targeting glioblastoma stem-like cells and methods of use thereof

Grant US-11780932-B2

United States of America

10 Oct 2023

Anti-CD146 antibodies and uses thereof

Grant US-11427648-B2

United States of America

30 Aug 2022

ANTIBODIES TARGETING GLIOBLASTOMA STEM-LIKE CELLS AND METHODS OF USE THEREOF

Application WO-2019074892-A1

World Intellectual Property Organisation (WIPO)

18 Apr 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.